학술논문
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
Document Type
Article
Author
Odia, Yazmin; Koschmann, Carl; Vitanza, Nicholas A; Blank, Peter de; Aguilera, Dolly; Allen, Jeffrey; Daghistani, Doured; Hall, Matthew; Khatib, Ziad; Kline, Cassie; MacDonald, Tobey; Mueller, Sabine; Faison, Shamia L; Allen, Joshua E; Naderer, Odin J; Ramage, Samuel C; Tarapore, Rohinton S; McGovern, Susan Lynne; Khatua, Soumen; Zaky, Wafik
Source
Neuro-Oncology; 2024 Supplement, Vol. 26, pS155-S164, 10p
Subject
Language
ISSN
15228517